The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects

This publication has 20 references indexed in Scilit:

• Improvement of the Intestinal Absorption of a Peptidomimetic, Boronic Acid Thrombin Inhibitor Possibly Utilizing the Oligopeptide Transporter
  Pharmaceutical Research, 1999
• Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers
  British Journal of Clinical Pharmacology, 1999
• Synthetic Inhibitors of Thrombin and Factor Xa
  Thrombosis Research, 1999
• Oral Anticoagulants
  Chest, 1998
• Benzylamine-based selective and orally bioavailable inhibitors of thrombin
  Bioorganic & Medicinal Chemistry Letters, 1998
• Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men
  Circulation, 1997
• Melagatran, hirudin and heparin as adjuncts to tissue-type plasminogen activator in a canine model of coronary artery thrombolysis
  Fibrinolysis and Proteolysis, 1997
• Argatroban analogs: Synthesis, thrombin inhibitory activity and cell permeability of aminoheterocyclic guanidine surrogates
  Bioorganic & Medicinal Chemistry Letters, 1994
• A PREPARATION FROM SPOILED SWEET CLOVER
  JAMA, 1942
• HYPOPROTHROMBINqMIA PRODUCED BY METHYLENE-BIS-(HYDROXYCOUMARIN) *1ITS USE IN THROMBOSIS
  The Lancet, 1942